Daidzein exerts anticancer activity towards SKOV3 human ovarian cancer cells by inducing apoptosis and cell cycle arrest, and inhibiting the Raf/MEK/ERK cascade. (Record no. 28153234)

MARC details
000 -LEADER
fixed length control field 01414 a2200361 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517203817.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201809s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1791-244X
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.3892/ijmm.2018.3531
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Hua, Fu
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20180910
245 00 - TITLE STATEMENT
Title Daidzein exerts anticancer activity towards SKOV3 human ovarian cancer cells by inducing apoptosis and cell cycle arrest, and inhibiting the Raf/MEK/ERK cascade.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. International journal of molecular medicine
Date of publication, distribution, etc. Jun 2018
300 ## - PHYSICAL DESCRIPTION
Extent 3485-3492 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Retracted Publication
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Agents
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Apoptosis
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cell Cycle Checkpoints
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cell Line, Tumor
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Isoflavones
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element MAP Kinase Signaling System
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Ovarian Neoplasms
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Proto-Oncogene Proteins c-raf
General subdivision metabolism
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Signal Transduction
General subdivision drug effects
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Li, Chang-Hua
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Chen, Xiao-Gang
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Liu, Xiao-Ping
773 0# - HOST ITEM ENTRY
Title International journal of molecular medicine
Related parts vol. 41
-- no. 6
-- p. 3485-3492
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.3892/ijmm.2018.3531">https://doi.org/10.3892/ijmm.2018.3531</a>
Public note Available from publisher's website

No items available.